Literature DB >> 12191814

Subthalamic locomotor region is involved in running activity originating in the rat ventromedial hypothalamus.

K Narita1, T Murata, K Honda, M Nishihara, M Takahashi, T Higuchi.   

Abstract

We have previously shown the involvement of the ventromedial nucleus of the hypothalamus (VMH) in inducing running behavior. Stimulation of kainate (KA)-type glutamate receptors in the unilateral VMH of the rat exclusively elicited stereotyped running behavior. However, the neural pathways or functional connections of the VMH neurons involved in the running activity are yet to be elucidated further. In this study we examined whether the subthalamic locomotor region (SLR) is involved in the expression of the running activity originating in the VMH. The multiunit activity (MUA) in the ipsilateral SLR was significantly increased by KA injection into the VMH of urethane-anesthetized animals. Concomitant injection of 6,7-dinitroquioxalline-2,3-dione (DNQX, a KA-type glutamate receptor antagonist) with KA blocked this change in the MUA. Unilateral pre-injection of either kynurenate (non-selective glutamate receptor antagonist), D-2-amino-5-phosphonovalerate (AP5, an NMDA-type glutamate receptor antagonist) or DNQX into the SLR blocked the expression of the running activity induced by KA injection into the ipsilateral VMH. Results from the present study suggest that communication between KA-sensitive efferents from the VMH to glutamatergic pathways acting via NMDA and non-NMDA receptors in the SLR may underlie expression of running behavior originating in the VMH. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12191814     DOI: 10.1016/s0166-4328(02)00041-4

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  Brain-derived neurotrophic factor (BDNF) in the hypothalamic ventromedial nucleus increases energy expenditure.

Authors:  Chuanfeng Wang; Eric Bomberg; Charles J Billington; Allen S Levine; Catherine M Kotz
Journal:  Brain Res       Date:  2010-04-14       Impact factor: 3.252

2.  Consequences of developmental exposure to concentrated ambient ultrafine particle air pollution combined with the adult paraquat and maneb model of the Parkinson's disease phenotype in male mice.

Authors:  Joshua L Allen; Xiufang Liu; Douglas Weston; Katherine Conrad; Günter Oberdörster; Deborah A Cory-Slechta
Journal:  Neurotoxicology       Date:  2014-01-30       Impact factor: 4.294

3.  An estrogen-responsive module in the ventromedial hypothalamus selectively drives sex-specific activity in females.

Authors:  Stephanie M Correa; David W Newstrom; James P Warne; Pierre Flandin; Clement C Cheung; Alexander T Lin-Moore; Andrew A Pierce; Allison W Xu; John L Rubenstein; Holly A Ingraham
Journal:  Cell Rep       Date:  2014-12-24       Impact factor: 9.423

4.  Impaired Glutamatergic Neurotransmission in the Ventromedial Hypothalamus May Contribute to Defective Counterregulation in Recurrently Hypoglycemic Rats.

Authors:  Golam M I Chowdhury; Peili Wang; Alisha Ciardi; Ramanaiah Mamillapalli; Justin Johnson; Wanling Zhu; Tore Eid; Kevin Behar; Owen Chan
Journal:  Diabetes       Date:  2017-04-17       Impact factor: 9.461

5.  Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease.

Authors:  Samer D Tabbal; Mwiza Ushe; Jonathan W Mink; Fredy J Revilla; Angie R Wernle; Minna Hong; Morvarid Karimi; Joel S Perlmutter
Journal:  Exp Neurol       Date:  2008-02-14       Impact factor: 5.330

6.  Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome.

Authors:  Nathan C Bingham; Kimberly K Anderson; Anne L Reuter; Nancy R Stallings; Keith L Parker
Journal:  Endocrinology       Date:  2008-02-07       Impact factor: 4.736

Review 7.  Automaticity of walking: functional significance, mechanisms, measurement and rehabilitation strategies.

Authors:  David J Clark
Journal:  Front Hum Neurosci       Date:  2015-05-05       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.